STIC Investment focuses on buyout and growth capital investments across diverse sectors and stages, targeting companies with intrinsic growth potential that require capital for expansion or business restructuring. Their strategy involves a value creation approach, utilizing an internal Operating Partners Group to develop and implement post-investment growth initiatives, while also integrating ESG considerations into their investment process.
Portfolio
10
Fund Size
$7.1B
Top Stage
Series A
Last 12 Mo
1
Stage Distribution
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| BreezeBio | Series B | — | Feb 2026 |
| Pinetree Therapeutics | Series A | $17M | Jul 2024 |
| BIORCHESTRA | Series C | $45M | Feb 2022 |
| Neosapience | Series B | $21.5M | Feb 2022 |
| PiLab Technology | Series A | $8.4M | Feb 2022 |
| 42dot | Series A | $88.5M | Nov 2021 |
| Carousell | Growth | $100M | Sep 2021 |
| HappyFresh | Series D | $65M | Jul 2021 |
| Ev Hive | Series A | $20M | Jun 2018 |
| H2, Inc. | Bridge | $16M | — |
Top Co-Investors
DSC Investment2 shared
IMM Investment1 shared
SBI Investment1 shared
LB Investment1 shared
Z Venture Capital1 shared
BRV Capital1 shared
Atinum Investment1 shared
Run Ventures1 shared
Shinhan Capital1 shared
WEH Ventures1 shared
SV Investment1 shared
Top Harvest Capital1 shared
Korea Investment Partners1 shared
Woori Venture Partners1 shared
SoftBank Ventures Korea1 shared
Naver1 shared
SMDV1 shared
Insignia Ventures Partners1 shared
Intudo Ventures1 shared
Last updated: 3 March 2026